Nancy Stagliano Email

CEO . Neuron23

Current Roles

Employees:
68
Revenue:
$5.3M
About
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 leverages recent advances in human genetics, combined with their state-of-the-art artificial intelligence (AI)-enabled drug discovery and biomarker platforms, to advance therapeutics for devastating diseases. The Company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA, and Munich, Germany.
Neuron23 Address
343 Oyster Point Blvd
San Francisco, CA
United States

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.